Bicycle Therapeutics (BCYC) PT Lowered to $8 at Citizens, Market Outperform Rating Maintained
Tweet Send to a Friend
Citizens analyst Reni Benjamin lowered the price target on Bicycle Therapeutics (NASDAQ: BCYC) to $8.00 (from $12.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
